Lord, Abbett & Co
ZYME icon

Lord, Abbett & Co’s Zymeworks ZYME Stock Holding History

Lord, Abbett & Co’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300,614
Closed -$10.8M – 694
2020
Q2 		$10.8M Sell
300,614
-19,081
-6% -$703K 0.04% 469
2020
Q1 		$11.3M Buy
+319,695
New +$13.1M 0.05% 409

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Lord, Abbett & Co's ZYME Position: Q3 2020 in Review

Lord, Abbett & Co sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 300,614 shares — an estimated $10.8M sold.

Lord, Abbett & Co first reported a position in ZYME in Q1 2020 and held it in 2 quarters. The position peaked at $11.3M in Q1 2020. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

  • Lord, Abbett & Co reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 300,614 Zymeworks shares in Q3 2020, an estimated $10.8M.
  • Lord, Abbett & Co first reported a position in Zymeworks in Q1 2020 and held it in 2 quarters.
  • Lord, Abbett & Co's Zymeworks position peaked at $11.3M in Q1 2020.
  • 127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Lord, Abbett & Co's 13F filing for Q3 2020, filed 12 Nov 2020.